Articles On Mach7 Technologies (ASX:M7T)

Small-cap shares suffered greatly during the period of 13 interest rate rises over 2022 and 2023. But with inflation cooling and the prospect of rate cuts coming, the little guys are starting to play catch up to the medium and large caps....

ASX health sector rises in line with broader markets in the past five days  AdAlta reports positive Phase 1 extension trial results of AD-214 into IPF Mach7 signs $3.1 million, three-year renewal contract with Penn State Health Morgans h...

    Wall Street falls, Nvidia soars BTC nears all-time highs Gold to move even further?   The ASX is poised to start flat on Tuesday, after overnight losses on Wall Street. At 8am AEDT, the ASX 200 index futures contract was pointing up...

Futures predict the ASX200 will trade mostly flat this morning, maybe down just a touch on open. US markets were down a little ahead of the next round of economic data. The Nasdaq dropped 0.4 per cent, the Dow Jones shed a quarter of...

ASX health sector lifts in line with broader markets as reporting season comes to end Morgans upgrades Polynovo as total revenue rises 65.6% on pcp to $48.8 million  Nanosonics cites hospital budgetary pressures as deferring purchasing dec...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AGI)) - Ainsworth Game Technology ((ART)) - Airtasker ((ALX)) - Atlas Arteria ((AFG)) - Australian Finance Group ((CAJ)) - Capitol Health ((CLU)) - Cluey ((DOC)) - Docto...

Here’s today’s The Match Out report from Market Matters’ James Gerrish. Key point: the S&P/ASX 200 (INDEXASX: XJO) finished down -0.40% to 6,948.80. A poor session to kick off the new trading week with the ASX snubbing the strength in...

ASX health stocks rise in past five days in line with broader markets Mach7 Technologies reports record quarterly sales orders for Q1 FY24 Aroa maintains FY24 revenue growth forecast at 30% after strong Q2 Healthcare and life sciences exp...

Mach7 Technologies reports third consecutive year of record sales growth in FY23 View on enterprise imaging extends beyond radiology CEO Mike Lampron says AI hurdles right now need to be overcome Morgans healthcare analyst Scott Power lik...

Mach 7 Tech is rated Overweight by Wilsons, with price target of almost double Goldman slapped a Buy rating on neobank Judo Capital   Wilsons says Mach7 could be worth almost double current price Wilsons has initiated coverage of Mach7 Te...

ASX health sector falls in line with broader markets as macroeconomic factors continue to create volatility Dimerix soars on $230m licensing deal with ADVANZ PHARMA for DMX-200 into rare kidney disease US FDA approves Cyclofarm’s lung imag...

ASX health sector rises in line with broader markets as reporting season comes to end EBR Systems on schedule for key US FDA submission in Q1 CY24 for (WiSE) CRT system Health imaging company Mach7 achieves record sales order book of $40.3...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((AIS)) - Aeris Resources ((AGI)) - Ainsworth Game Technology ((ALX)) - Atlas Arteria ((ATA)) - Atturra ((AUA)) - Audeara ((ASB)) - Austal ((BUB)) - Bubs Australia ((CCX))...

Medical devices offer faster route to commercialisation than drugs How newly listed Curvebeam AI aims to grab market share Stockhead reached out to Curvebeam AI CEO, Greg Brown   Despite the recent rally, the ASX Healthcare Index (XHJ) is...

ASX health sector falls in mixed week of FY23 results as reporting season continues Monash IVF reports solid FY23 result and forecasts higher IVF cycles going forward Ramsay healthcare plunges on disappointing FY23 result and cut in final...

ASX health stocks fall 2.4% in the past five days in line with broader markets Mesoblast crashes more than 50% after US FDA rejects a key product  ImpediMed falls after calls for board spill with discontent following cap raise Healthcare...

The Mach7 Technologies Ltd (ASX: M7T) share price is having a strong finish to the week. In morning trade, the ASX health technology share is up 7% to a 52-week high of 97.5 cents. Why is this ASX share shooting higher? Investors have been...

The ASX will open lower on Friday as earnings weighed on Wall Street The “fear gauge” CBOE index is at lowest since 2020 Bitcoin spot ETFs to significantly increase BTC demand, says analyst   Local shares are set to open lower on Friday a...

ASX health stocks have fallen in the past five days in line with broader markets Mach7 wins a US$60 million Veterans contract – the most significant in its history Neuren completes recruitment for Phase II trial of NNZ-2591 in Phelan-McDer...

Lumos soars after US FDA approval for FebriDx rapid, point-of-care test Emyria will buy the Pax Centre for $1.7 million following psychedelic medicine law changes in Australia Rhythm Biosciences establishes UK subsidiary as part of strateg...

Clinical validation study confirms efficacy of INOVIQ’s SubB2M/CA15-3 test for breast cancer Ramsay releases several announcements this week including possible sale of joint Asian venture Mach 7 expects significant cash collections in Q4...

ASX health stocks rise in the past five days in line with broader markets Immutep  surges 46% after positive Phase 2 results into lung cancer Avita Medical falls 28% in past five days despite reporting “solid Q1 FY23” results Healthcare a...

ASX health stocks fall 0.8% in the past five days in line with broader markets following latest rate hike Investors rewarding health stocks with near term catalysts in 2023, including Neuren and Impedimed Health imaging stock Volpara recor...

Mach7 primed for growth as move towards enterprise rather than departmental imaging grows Company’s three modular products are a unique fit for use case of enterprise imaging Mach7 landing big clients as it works to solve tomorrow’s probl...

The medical imaging market size globally is forecast to reach $68.8 Billion by 2030 Several ASX health imaging stocks are establishing strong footholds and niches in sector Micro-X branching out from the medical sphere with its bomb detect...

Mach7 (M7T) receives a $7.1 million order from Adventist Health for Mach7 picture archiving and communication systems (PACS) for another 15 hospitals This marks the final deployment phase of a 22-hospital contract signed in January 2021,...

ASX health stocks fall 1.87% in the past five days as reporting season ends Healius moves to a statutory loss of ~$29 million following reduced demand for Covid-19 testing Catalysts in next few months for several ASX health stocks which co...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ABC)) - Adbri ((AHL)) - Adrad ((AIS)) - Aeris Resources ((AMX)) - Aerometrex ((AOF)) - Australian Unity Office Fund ((AVG)) - Australian Vintage ((BBT)) - BlueBet Holdin...

The ASX is set to track Wall Street and move higher at the open The DoE says Covid-19 came from a ‘lab leak’ Coinbase to suspend trading of Binance USD   The ASX is set to open stronger on Tuesday after US stocks rose in New York. At 8am...

ASX health stocks fall 1.2% in the past five days  as macro economic factors weigh on broader markets Monash IVF has reported a solid H1 FY23 result with underlying NPAT of $12.6m, ahead of guidance Pharmaceutical distribution group  EBOS...

If you have a high tolerance for risk, then you might want to consider adding some small cap exposure to your portfolio. But which small cap ASX shares should you buy? Listed below are two that Morgans rates very highly. Here’s why it is...

ASX health stocks rise 4.6% this week with positive signs of being back in favour Volpara soars after announcing its first net cash flow positive quarter Morgans basket of healthcare stock picks for 2023 faring well,  all up YTD Healthca...

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

ASX health stocks rise 0.8% this week as smaller names in sector show signs of being back in favour Volpara signs five 5-year contracts worth more than US$7.8 million in Total Contract Value Mach 7 continues its 2023 recovery after announc...

The ASX Health sector has fallen ~1.5% in its first trading week of 2023 Mach7  has surged after landing its largest ever customer contract Proteomics gets US approval for PromarkerD test for diabetic kidney disease Healthcare and life sc...

It’s certainly been a rollercoaster for ASX investors in 2022. But now, it’s time to disembark and begin a whole new ride! Will rising inflation and recession fears derail the carriage again in 2023? Or will China fully reopen and central...

2023 off to a bit of a dismal start, down 1.3% on the opening day of trade GreenX soaring after rumblings from Poland over $1.3 billion payday Chinese markets gain before the rest of the trading world gets back from holidays   For about 1...

Highlights Mach7 entered a customer contract with Akumin Inc. The company expects to recognise revenue of AU$7.5 million in FY23 through this largest-ever customer contract. The contract has been signed under a 10-year term with a tot...

The Mach7 Technologies Ltd (ASX: M7T) share price has jumped after the company announced a multi-year contract worth $16.7 million. This business is a medical imaging systems provider that develops image management and viewing solutions for...

Mach7 signs up biggest client in its history Proteomics gets major regulatory approval in the US   ASX medical imaging specialist Mach7 Tech (ASX:M7T) surged 20%  to ~4 month highs on the first trading day of 2023 after landing the larges...

This content is created by Smallcaps Authors. [Author : Imelda Cotton] Medical imaging software solutions provider Mach7 Technologies (ASX: M7T) has kicked off the new year with a $16.7 million order for its enterprise imaging platform fr...

The Mach7 Technologies Ltd (ASX: M7T) share price is off to the races on this first day of trading in 2023. Shares in the ASX listed medical imaging systems provider leapt more than 20% on open and are currently up 18.4% in morning trade....

The ASX is poised to open higher on the first day of 2023 Wall Street had one of its worst years in 2022 IMF warns of a tougher year   Aussie shares are set to advance on the first trading day of the year. At 8am AEDT, the ASX 200 Jan fut...

Mach7 Technologies (M7T) signs a ten-year deal with Akumin to consolidate its system into a common enterprise solution for $16.7 million The agreement involves the company’s entire enterprise imaging platform to provide a true cloud-base...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) has followed Wall Street’s lead and dropped into the red. At the time of writing, the benchmark index is down 0.55% to 7,094.7 points. Four ASX shares that are not letting that ho...

Medical imaging is back in demand in the post-covid world and Mach7 Technologies seems an undervalued player By Tim Boreham Observers of the medical imaging space - your columnist included - have delighted in highlighting the yawning gap be...

During latest period of volatility many health stocks have seen their share prices remain quite stable Several ASX health stocks have rallied this week on positive news including Polynovo on $5 million sales month Telix Pharmaceuticals ral...

In this week's Weekly Insights:-Inflation & House Prices-Conviction Calls-Research To DownloadBy Rudi Filapek-Vandyck, Editor Inflation & House PricesOne of the more eye-catching forecasts made recently is that persistent inflation...

Wanting some ASX small caps in your portfolio? If you are, check out the two listed below that Morgans rates as buys. Here’s what the broker is saying about these small caps: Acrow Formwork and Construction Services Ltd (ASX: ACF) The...

ShareCafeWebinar Recap – XPN, M7T, SHP & NMT Catch up on the full webinar presentations from Xpon Technologies (ASX: XPN), Mach7 Technologies (ASX: M7T), South Harz Potash (ASX: SHP) & Neometals (ASX: NMT) Webinar Recap – XPN, M7T,...